Authors: Berry, W Dakhil, S Gregurich, MA Asmar, L

Citation: W. Berry et al., Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate, SEMIN ONCOL, 28(4), 2001, pp. 8-15